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Sindbis virions contain two glycoproteins, El and E2. E2 is produced initially as a precursor, PE2, from
which the amino-terminal 64 amino acids are cleaved by a cellular protease at a late stage in virion maturation.
A mutation at E2 position 1 (Arg to Asn) was placed into Sindbis virus AR339 by site-directed mutagenesis of
a full-length AR339 cDNA clone, pTRSB, to produce pTRSB-N. The mutation created a signal for N-linked
glycosylation immediately adjacent to the PE2 cleavage signal. Virions derived from pTRSB-N were
glycosylated at E2 position 1, and they quantitatively incorporated PE2 in place of E2. When pTRSB-N
transcripts were electroporated into BHK-21 cells, TRSB-N particles were released with nearly normal
efficiency; however, the specific infectivity of TRSB-N particles was very low. Analysis of seven infectious
revertants of TRSB-N revealed that reversion was linked to (i) mutations that eliminated the signal for
N-linked glycosylation and thus restored the PE2 cleavage phenotype or (ii) conservation of the PE2 cleavage
defect combined with incorporation of suppressor mutations in E3 or E2. The genotype of each revertant was
reconstructed in the genetic background of TRSB-N, and each reverting mutation also was replaced
individually into the genetic background of wild-type virus (TRSB). Each PE2-containing revertant was
attenuated in newborn CD-1 mice and replicated poorly in cultured mosquito cells (C6/36). Reverting
mutations in the genetic background of TRSB did not reduce virulence in mice or growth in mosquito cells,
suggesting that the phenotypes of attenuation in mice and reduced growth in mosquito cells were linked to
failure of PE2 cleavage and not to the reverting mutations themselves.
The membrane glycoproteins comprising the spikes of en-
veloped viruses perform many important viral functions.
Among these are attachment of virus to specific host cell
receptors, fusion of the viral envelope with host cell mem-
branes, budding from infected cells, and influencing pathoge-
nicity in vivo. These functional properties of viral spikes are a
direct consequence of the structure(s) of the individual spikes
and their constituent components, which can vary depending
upon their maturational state (9, 24, 33). The maturation
process of enveloped RNA viruses often involves the proteo-
lytic cleavage of a membrane glycoprotein precursor prior to
release of virions from the cell. For most viruses of the
orthomyxovirus, paramyxovirus, coronavirus, and retrovirus
families, the fusogenic glycoproteins are synthesized as nonfu-
sogenic precursors, which attain fusion competence at a late
stage of viral maturation through a specific proteolytic event
(see reference 67 for a review). A similar maturational event
occurs during the morphogenesis of alphaviruses (family To-
gaviridae).
The alphavirus genome consists of a positive-sense, single-
stranded RNA which is encapsidated within a T=4 nucleocap-
sid composed of 240 copies of capsid protein (3, 42). The
nucleocapsid is contained within a host cell-derived lipid
envelope (17). Two transmembranal viral glycoproteins, El
and E2, are exposed on the surface of the virion (49, 54). El
and E2 are associated as heterodimers, which in turn are
organized in groups of three to form the viral spikes. The viral
spikes are structured in an icosahedral form at the virus surface
and are arranged with a T=4 symmetry (13, 41, 61).
The structural proteins of alphaviruses are translated as a
single polyprotein from the 26S subgenomic mRNA (53).
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During their synthesis, glycoproteins PE2, the precursor of E2,
and El are cleaved from the common precursor as nascent
peptides and inserted individually into the endoplasmic retic-
ulum (see reference 55 for a review). PE2 and El associate in
the endoplasmic reticulum (49, 63, 68) and are processed and
transported in heterodimeric form (11, 38). Within either a
trans- or post-Golgi compartment, PE2 is cleaved into E3 and
E2 (23, 56). E3 is composed of the 64 (Sindbis virus) or 66
(Semliki Forest virus [SFV]) amino-terminal residues of PE2.
E3 is retained in the SFV particle but is lost to the medium in
Sindbis virus-infected cell cultures (14, 66). The larger cleavage
product, E2, remains anchored in the membrane and associ-
ated with El. PE2 cleavage is likely performed by a host cell
protease (8, 40, 65) and occurs at a site immediately following
a highly conserved canonical four-residue motif, Basic amino
acid-X-Basic-Basic (5, 48). Cleavage of PE2 temporally coin-
cides with the release of budded particles which contain
structurally and functionally mature E2/E1 heterodimers. Mu-
tants of SFV and Sindbis virus that fail to cleave PE2 but are
still efficiently released from infected cells have been isolated
(10, 50, 51). All of these viruses have defects in one or more
biological functions, which can be linked to the presence of
PE2 in virions.
In SFV, cleavage of PE2 was prevented by mutating the PE2
cleavage signal from Arg-His-Arg-Arg to Arg-His-Arg-Leu
(29, 51). PE2-containing particles were efficiently released
from transfected cells; however, these were not infectious for
baby hamster kidney (BHK-21) cells because of impairment in
functions of receptor binding and entry (51). However, when
inoculated into 40-day-old mice, the particles displayed an
attenuated phenotype but were not avirulent (15). This indi-
cates that these particles were infectious to some extent in vivo
or that infectious revertants were present in the virus prepa-
rations. Infectivity for BHK-21 cells could be restored by in
vitro cleavage of PE2 in virions with trypsin or by exposing
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particles to pH 4.5 (51). Both treatments have demonstrable
effects on heterodimer stability and virion structure (22, 29, 30,
63). Likewise, PE2-containing mutants of Sindbis virus, defec-
tive in functions of cell binding and penetration, have been
produced by disruption of the cleavage signal through inser-
tional mutagenesis (10). Consistent with these findings was the
observation that particles of Sindbis virus AR339 released
from RPE.40 cells, which are defective for the cellular protease
thought to be responsible for PE2 cleavage, contained PE2/E1
heterodimers and were essentially noninfectious (65).
Interestingly, the link between PE2 cleavage and virion
infectivity appears to differ among Sindbis virus strains. A
PE2-containing mutant of the S.A.AR86 strain of Sindbis virus
was isolated during selection for variants having a rapid-
penetration phenotype (50). The PE2 processing defect in this
mutant, S12, resulted from a single mutation at E2 amino acid
1 (E2 1), the + 1 position relative to the cleavage site, in which
a Ser-to-Asn substitution created a signal for N-linked gly-
cosylation (Asn-X-Ser/Thr). In BHK-21 cells, S12 was as
infectious as the PE2-cleaving parent (50) and both viruses
grew to normal titers on RPE.40 cells (65). In contrast, S12 was
markedly attenuated in newborn and adult CD-1 mice in
comparison with the PE2-cleaving parent (50) and grew very
poorly in cultured mosquito cells (46).
In this report, we have used a full-length cDNA clone of
Sindbis virus AR339 to study the differential strain require-
ments for cleavage maturation of the PE2 precursor. A single
mutation analogous to that identified in S12 was engineered
into the clone by site-directed mutagenesis. The resulting
substitution, Asn for Arg at E2 1, produced a signal for
N-linked glycosylation, which was utilized and which proved to
be lethal. PE2-containing particles were released with high
efficiency following electroporation of transcripts from the
mutant clone into BHK-21 cells; however, these were essen-
tially noninfectious. Infectious PE2-containing virus could be
rescued by a number of second-site suppressor mutations
which mapped to the E3 or E2 gene. Each reverting mutation
displayed a considerable degree of specificity for the original
lesion at E2 1. Consistent with studies using the S12 mutant,
PE2-containing AR339 revertants grew to nearly normal titers
in RPE.40 cells, were markedly attenuated in newborn mice,
and were restricted for growth in cultured mosquito cells.
MATERMILS AND METHODS
Viruses and cell lines. Sindbis virus AR339 was obtained
originally from H. R. Bose (University of Texas at Austin).
TRSB was derived from an infectious, full-length cDNA clone
(pTRSB) containing viral sequences from our laboratory strain
of AR339 (SB) placed downstream of an SP6 phage promoter
(33a). Briefly, SB sequence fragments isolated from a cDNA
library (43) were substituted for analogous fragments removed
from the original Sindbis virus cDNA clone, TotollOl, de-
scribed by Rice et al. (47). Sindbis virus S.A.AR86 was
obtained through J. M. Dalrymple from J. Casals, Yale Arbo-
virus Research Unit. The passage history of this virus has been
described elsewhere (50). The nomenclature identifying the
viruses used in these studies is as follows. The prefix TRSB-
was assigned to all mutant viruses constructed in either pTRSB
or pTRSB-N (see the explanation below). Designations for
biologically derived mutants lack this prefix. All virus stocks
used in this study were grown in ATCC BHK-21 cells main-
tained as previously described (50). A parental line of Chinese
hamster ovary cells (CHO-Ki) and a Pseudomonas exotoxin
A-resistant mutant strain (RPE.40) were kindly provided by
J. M. Moehring and T. J. Moehring (University of Vermont)
(35). CHO-Ki and RPE.40 cells are auxotrophic for proline
and were maintained in Eagle's minimal essential medium
(MEM) (GIBCO-BRL) supplemented with 5% donor calf
serum, penicillin (50 U/ml), and streptomycin (50 jig/ml). The
invertebrate cell line, C6/36, was derived from Aedes albopictus
cells by A. Igarashi (20) and was provided to us by D. T. Brown
(University of Texas at Austin). C6/36 cells were maintained in
MEM supplemented with 10% fetal bovine serum, 10% tryp-
tose phosphate broth, and antibiotics as described above.
General recombinant DNA methods. DNA manipulations
and plasmid DNA preparations were carried out essentially as
described previously (31, 44). DNA fragments used in cloning
procedures, and products from PCR procedures, were isolated
in agarose gels and recovered with Geneclean (Bio 101, Inc.,
La Jolla, Calif.).
In vitro mutagenesis. Single codon substitutions were engi-
neered into genetically defined cDNA clones by in vitro
mutagenesis by the technique of Kunkel et al. (25). Mutagen-
esis was performed as described previously (44, 45), by using
the M13-derived mutagenesis substrate vectors mp18SBGP
and mpl8SBGP-N and site-specific mutagenesis primers, each
containing one or two mismatched nucleotides. mpl8SBGP
contains the PE2, 6K, and El gene sequences of SB.
mpl8SBGP-N is isogenic with mpl8SBGP except for a single
codon substitution (Asn for Arg) at E2 1. Individual phage
clones were screened by sequence analysis of single-stranded
phage DNA by the dideoxynucleotide chain-termination
method (52). The unique restriction sites StuI (nucleotide
8571) and BssHII (nucleotide 9804) were utilized to generate
restriction fragments from phage replicative-form DNA con-
taining the desired substitutions. These were substituted for
the analogous fragment removed from pTRSB. Each recom-
binant cDNA was sequenced across the entire replacement
region by the Taq cycle sequencing procedure (United States
Biochemical).
In vitro transcription and transfection of cells. BHK-21 cells
were routinely transfected with in vitro transcripts for the
production of virus stocks and for specific infectivity assays
with Lipofectin reagent (GIBCO-BRL), as described previ-
ously (43, 44). Electroporation of in vitro transcripts into
BHK-21 cells was performed as described earlier (28).
Specific infectivity assays were performed essentially as
described by Rice et al. (47). For each construct to be tested,
duplicate transcription mixes were prepared, one of which was
supplemented with S p.Ci of 35S-UTP. The quantity of incor-
porated label was measured for 1 RI of transcripts spotted onto
DE81 ion exchange paper (Whatman) and quantitated on a
liquid scintillation counter. Two microliters of unlabelled
transcripts was transfected into duplicate 60-mm-diameter
dishes of BHK-21 cells, and the cells were overlaid with
agarose (0.9% in MEM complete) after a 20-min incubation.
Plaques were visualized 30 to 48 h later by staining with neutral
red, and the specific infectivity of transcripts was calculated as
PFU per counts per minute.
Isolation and sequence analysis of revertant viruses. Indi-
vidual plaques that formed in specific infectivity assays using
transcripts from pTRSB-N were picked with a 1.0-cm3 tuber-
culin syringe, diluted into 1.0 ml of MEM (serum free), and
placed onto BHK-21 cell monolayers in 25-cm2 culture flasks.
These plaque isolates were used as working stocks for the
determination of biological revertant phenotypes.
Purification of virions and sequencing of virion RNA were
done essentially as described previously (39, 50), except that
sodium dodecyl sulfate (SDS)-disrupted virions were first
digested with proteinase K (50 ,ug/ml) for 30 min at 37°C prior
to extraction with phenol-chloroform (1:1 [vol/vol]) and pre-
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cipitation in ethanol. Viral RNA was sequenced by the
dideoxynucleotide chain-termination method, using modifica-
tions designed for sequencing RNA templates (6, 69). The
oligonucleotide primers used for sequencing have been de-
scribed previously (6, 50).
cDNA constructions of revertant genotypes by PCR. The
genotype of each biological revertant was reconstructed in
pTRSB-N. A reverse transcriptase-PCR procedure was used to
obtain each reverting mutation in double-stranded DNA form.
cDNA derived from virion RNA was amplified by PCR for 20
cycles with Taq DNA polymerase (Perkin-Elmer Cetus) in a
model 480 thermocycler (Perkin-Elmer Cetus).
PCR fragments derived from revertants with mutations in
E2 were digested with StuI and BssHII at unique restriction
sites, generating fragments containing both the primary muta-
tion at E2 I and the reverting mutation. Fragments containing
the reverting mutation in E3 were digested at the unique sites
AatlI (nucleotide 7999) and StuI. Restriction enzyme-digested
PCR fragments containing the E2 reverting mutations were
ligated into pTRSB from which the analogous StuI-to-BssHII
fragment had been removed. Colonies were screened by
sequencing transcripts (synthesized in vitro as described
above) across the PE2 cleavage site, where the presence of E2
Asn-1 confirmed each PCR replacement. Restriction enzyme-
digested PCR fragments containing the E3 mutation were
ligated into pTRSB-N or pTRSB by using transcript sequenc-
ing to confirm proper replacement. Reverting mutations in E2
were placed into pTRSB by site-directed mutagenesis. Specific
infectivities were determined for transcripts from each cDNA
construct, and each StuI-to-BssHII or AatII-to-StuI replace-
ment was sequenced in its entirety from virion RNA as
described earlier.
Polyacrylamide gel analysis of [35S] methionine-labelled
viral proteins. Viral proteins of TRSB-N, and of all the
biological and cloned mutants, were radiolabelled with
[35S]methionine and visualized by SDS-polyacrylamide gel
electrophoresis (SDS-PAGE) and autoradiography. BHK-21
monolayers were electroporated with transcripts from
pTRSB-N or infected with viable virus at a multiplicity of
infection of 10 PFU per cell. Cells were maintained in MEM
complete for 5 h. Cells were then depleted of methionine for
an additional 3 h by replacement of media with antibiotics and
methionine-free MEM supplemented with 5% donor calf
serum. At 8 h after electroporation or infection, [35S]methi-
onine was added to a final concentration of 20 ,uCi/ml, and
cells were incubated at 37°C for an additional 12 h. Virus
particles, purified from the culture supernatants, were ana-
lyzed on SDS-polyacrylamide gels (10% acrylamide) prepared
as described previously (26). 14C-methylated protein markers
(Amersham) were included as molecular weight standards.
Labelled proteins were visualized by fluorography (Amplify
solution; Amersham).
Virulence studies in newborn CD-1 mice. Two to four litters
of 1-day-old CD-1 mice (Charles River Breeding Laboratories
Inc., Wilmington, Mass.) were infected with each virus by
subcutaneous inoculation of 100 PFU of the virus in 50 [L of
phosphate-buffered saline (without Mg2+ or Ca2+) (PBS-D)
containing 1% donor calf serum (PBS-D 1%). Two mice from
each litter were inoculated with 50 [l of PBS-D 1% only and
served as noninfected controls. Mice were observed daily
through 14 days postinoculation for calculations of percent
mortality and average survival times of animals that died.
Viral growth in BHK-21, CHO-Ki, RPE.40, and C6/36 cells.
Growth curves were determined for selected viruses in BHK-
21, CHO-KI, and RPE.40 cells. Duplicate 60-mm dishes were
infected with each virus at a multiplicity of infection of 5 PFU
per cell. The virus was allowed to adsorb to cells for 30 min at
37°C. Monolayers were then washed twice with PBS-D 1%,
overlaid with 4 ml of media, and incubated at 37°C. Samples
were obtained at intervals postinfection and were quantitated
by plaque assay on BHK-21 cells. In a separate experiment,
peak titers for all viable viruses on each cell line were
determined by plaque titration on BHK-21 cells.
Growth curves for all viable viruses also were determined in
the C6/36 invertebrate cell line. In this case, the multiplicity of
infection was 2 PFU per cell and incubation was at 28°C.
RESULTS
Construction and characterization of TRSB-N. pTRSB is a
full-length cDNA clone containing the viral sequences of
Sindbis virus AR339 placed downstream of an SP6 phage
promoter. pTRSB was constructed by replacing all viral se-
quences of the Totol 01 cDNA clone (47) with those of our
laboratory strain of Sindbis virus AR339 (SB) (33a). A single
mutation, analogous to that identified in S.A.AR86-S12, was
generated in the genetic background of Sindbis virus AR339 by
site-directed mutagenesis of pTRSB. The mutant construct,
designated pTRSB-N, substituted Asn (AAC) for the Arg
codon at E2 1 (AGA). This substitution introduced a signal for
N-linked glycosylation (Asn-Val-Thr) immediately adjacent to
the site of PE2 cleavage. To determine whether the introduced
mutation affected construct viability, transcripts derived from
pTRSB and pTRSB-N were compared in a specific infectivity
assay. The specific infectivity of pTRSB-N transcripts was
reduced by a factor of approximately 350 below that of pTRSB
(data not shown), and only occasionally did plaques appear on
pTRSB-N assay dishes. This indicated that the introduced
mutation was lethal.
The following experiment suggested that an early event was
blocked by this mutation. BHK-21 cells were electroporated
with pTRSB or pTRSB-N transcripts and radiolabelled with
[I35S]methionine. Supernatants were harvested at 18 to 24 h
postelectroporation to minimize amplification of possible re-
vertants. Particles were isolated from the supernatants and
analyzed by SDS-PAGE. TRSB particles were composed al-
most exclusively of E2 and El; however, a small amount of PE2
was consistently present. Particles derived from pTRSB-N
(TRSB-N) quantitatively substituted PE2 for E2 in virions
(Fig. 1). In addition, PE2 from TRSB-N displayed decreased
mobility in SDS-PAGE, suggesting that the introduced gly-
cosylation signal at E2 1 was utilized (Fig. 1). Quantitation of
labelled particles released from electroporated BHK-21 cells
indicated that TRSB-N particles were released with greater
than 90% efficiency relative to TRSB (100%); however, the
specific infectivity of the TRSB-N particles on BHK-21 cells
was reduced by a factor of 320 below that of TRSB particles
(data not shown). Therefore, the effects of PE2 incorporation
on replication and release of particles from cells were minimal
but these PE2-containing particles were unable to initiate the
infection of additional cells. We infer that the presence of PE2
in virions impaired an early event, since the block could be
bypassed by direct introduction of RNA.
Isolation and sequence analysis of viable TRSB-N rever-
tants. The rare appearance of plaques after transfection of
pTRSB-N transcripts or infection with TRSB-N virions sug-
gested that this block to infection occasionally was overcome.
This could occur by low-frequency infection initiated by gen-
erally noninfectious, PE2-containing virions or by reversion of
the TRSB-N phenotype. Seven individual plaques were iso-
lated from agarose-overlaid BHK-21 cells transfected with
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FIG. 1. SDS-PAGE analysis of glycoproteins present in wild-type
virus (TRSB) and the noninfectious mutant (TRSB-N). BHK-21 cells
were electroporated with in vitro transcripts, and virions were labelled
metabolically with [35S]methionine. Virions were purified from cell
supernatants as described in the text. '4C-methylated proteins were
included as molecular weight markers (MWM; indicated on the left in
thousands).
pTRSB-N transcripts to determine whether these viruses re-
tained the genotype and/or PE2 cleavage phenotype of
TRSB-N. These were cloned by plaque purification and passed
once in BHK-21 cells for production of virus stocks. The PE2
cleavage phenotype of each isolate was determined by SDS-
PAGE analysis of [35S]methionine-labelled proteins from pu-
rified particles. Five of the viruses quantitatively incorporated
PE2 into virions; and two viruses had reverted to the PE2
cleavage phenotype and incorporated E2 (Fig. 2).
RNA from each virus was initially sequenced across the E2
region containing the glycosylation signal at E2 1. A Thr-to-
Pro mutation at E2 3 was identified in revertant N7R1, and





FIG. 2. SDS-PAGE analysis of wild-type virus (TRSB) and seven
biological revertants of TRSB-N. Virions were metabolically labelled
with [35S]methionine and purified from infected-cell supernatants as
described in the text. 14C-methylated proteins were included as
molecular weight markers (MWM; indicated on the left in thousands).
Lane A, TRSB; lane B, N6R1; lane C, N7R1; lane D, N7R2; lane E,
N7R3; lane F, N8R1; lane G, N8R2; lane H, N8R3. C, capsid protein.
revertant N7R2 had incorporated an Asn-to-Asp substitution
at E2 1 (Table 1). In both viruses, disruption of the N-linked
glycosylation signal at E2 1 correlated with reversion to the
PE2 cleavage phenotype. Therefore, these mutations were
presumed to be solely responsible for the revertant phenotypes
of these viruses. N7R1 and N7R2 were designated group 1
revertants and were not sequenced further.
The five viruses that retained the PE2 cleavage defect also
retained the glycosylation signal at E2 1. Sequencing across the
entire E3 and E2 genes revealed that each virus had incorpo-
rated either one or two additional point mutations (Table 1).
These viruses were designated group 2 revertants. Revertant
N6R1 had a single mutation, Arg for Cys at E3 25, and
provided the only example of a reverting mutation in E3. The
mutations identified in revertants N8R1, N8R2, N7R3, and
N8R3 all occurred within E2 (Table 1). Revertant N8R1 had a
Thr-for-Pro substitution at E2 191, and revertant N8R2 had a
His-for-Asn substitution at E2 239. Revertants N7R3 and
N8R3 were double mutants. N7R3 had substitutions at E2 169
(Leu for His) and E2 198 (Met for Thr). The mutation at E2
198 eliminated one of the two natural N-linked glycosylation
signals on E2 (at E2 196) (6). Predictably, this mutation
increased the mobility of PE2 in SDS-PAGE compared with
that for TRSB-N (Fig. 2). Mutations identified in N8R3 were
Asp to Gly at E2 82 and Glu to Gly at E2 216.
To confirm the linkage between the candidate group 2
reverting mutations and the revertant phenotype, these muta-
tions were reconstructed in the genetic background of
pTRSB-N, as described in Materials and Methods. Transcripts
derived from each clone were then tested for specific infectivity
in BHK-21 cells. In every instance, replacement of the candi-
date mutations into the genetic background of the nonviable
TRSB-N parent resulted in reversion to viability. In addition,
the cloned revertants and cognate biological revertants shared
identical PE2 cleavage phenotypes and glycoprotein migration
patterns, as revealed by SDS-PAGE (data not shown).
Group 2 revertants N7R3 and N8R3 each contained two
potentially reverting mutations. To determine whether both
mutations were required for the revertant phenotype of N7R3
and N8R3, individual mutations were placed into pTRSB-N by
site-directed mutagenesis. On the basis of the clustering of
most group 2 mutations within an antigenically important
region of E2 (see the description below), only the E2 198
(N7R3) and E2 216 (N8R3) mutations were replaced. Individ-
ually, each of these single mutations was sufficient to revert
TRSB-N. Viruses derived from these constructs (TRSB-
NE2M198 and TRSB-NE2G216) were viable by specific infec-
tivity and shared the PE2 cleavage and gel migration pheno-
types of their cognate biological mutants which contained two
putative reverting mutations. Therefore, it appeared that the
second mutations in N7R3 (E2 169) and in N8R3 (E2 82) were
not necessary for the revertant phenotype of these viruses.
With the exception of group 1 revertants, viruses derived from
the cDNA clones were used in all subsequent analyses.
Construction of reverting mutations in the genetic back-
ground of TRSB. In addition to incorporating PE2 into virions,
group 2 revertants displayed several other phenotypic differ-
ences from TRSB (see the description below). In order to
unequivocally link individual mutations to these specific phe-
notypic differences, each reverting mutation also was analyzed
individually in TRSB, a genetic context that was wild type at E2
1 (Table 1). Transcripts derived from these constructs were as
infectious as those from pTRSB. In addition, all of these
viruses incorporated E2 and El into virions and grew in
BHK-21 cells to titers comparable to those of TRSB (data not
shown).
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TABLE 1. Genetic and phenotypic characteristics of biological and cloned viruses used in this study
GIycsyIltonSign l PE2Virus type, group, and clone Mutation(s) Glycosylation signalat E2 1-3 cleavage"
Parental
TRSB Wild type Not present Yes
TRSB-N E2 1 Arg to Asn Created No
Biologically derived revertant"
Group 1
N7Ro E2 3 Thr to Pro Lost Yes
N7R2 E2 1 Asn to Asp Lost Yes
Group 2
N6R I E3 25 Cys to Arg Intact No
N7R3 E2 169 His to Leu, Intact No
E2 198 Thr to Met
N8Rl E2 191 Pro to Thr Intact No
N8R2 E2 239 Asn to His Intact No
N8R3 E2 82 Asp to Gly, Intact No
E2 216 Glu to Gly
Cloned
Mutations constructed in pTRSB-N (E2 Asn-l)
TRSB-N6R2 E3 25 Cys to Arg Intact No
TRSB-N7R3 E2 169 His to Leu, Intact No
E2 198 Thr to Met
TRSB-N8Rl E2 191 Pro to Thr Intact No
TRSB-N8R2 E2 239 Asn to His Intact No
TRSB-N8R3 E2 82 Asp to Gly, Intact No
E2 216Gru to Gly
TRSB-NE2MI98 E2 198 Thr to Met Intact No
TRSB-NE2G216 E2 216 Glu to Gly Intact No
Mutations constructed in pTRSB (E2 Arg-1)
TRSB-E3R25 E3 25 Cys to Arg Not present Yes
TRSB-E2T191 E2 191 Pro to Thr Not present Yes
TRSB-E2MI98 E2 198 Thr to Met Not present Yes
TRSB-E2G216 E2 216 Glu to Gly Not present Yes
TRSB-E2H239 E2 239 Lys to His Not present Yes
"Determined by SDS-PAGE analysis of purified virions.
Characteristics relative to TRSB-N.
Virulence of revertant viruses in newborn CD-1 mice. In the
genetic background of Sindbis virus S.A.AR86, failure to
cleave PE2 correlated with attenuation of the virus in newborn
and adult CD-1 mice (50). To determine whether these
phenotypes were linked in the genetic background of Sindbis
virus AR339, the virulence phenotype of each viable virus was
compared with that of TRSB. Virulence was assessed only in
newborn CD-1 mice, as Sindbis virus AR339 is not virulent in
adults. Viruses were categorized as virulent (causing 100%
mortality) or attenuated (less than 100% mortality and/or
increased average survival time). All control pups (PBS-D 1%
inoculated) survived through the observation period and ap-
peared normal. The two revertants that cleaved PE2 (group 1)
were as virulent as TRSB. In addition, each of the five viruses
containing only the reverting mutations in the genetic back-
ground of TRSB displayed virulence characteristics similar to
those of TRSB (Table 2). All viruses that cleaved PE2 caused
100% mortality and displayed average survival time values
ranging from 2.7 ± 0.4 days for N7R2 to 6.0 ± 1.3 days for
TRSB-E2H239.
Virulence characteristics were markedly different for the
viruses that failed to cleave PE2. The viable PE2-containing
revertant viruses were attenuated in neonatal CD-1 mice, each
causing less than 100% mortality and allowing significantly
extended survival compared with that of animals succumbing
to TRSB (Table 2). Viruses containing the same reverting
mutations placed into the genetic background of TRSB were
not attenuated. Therefore, attenuation was linked only to the
PE2 noncleavage phenotype of these viruses and not to the
reverting mutations themselves.
Growth of TRSB and revertants in CHO-KI and RPE.40
cells. PE2 cleavage can be inhibited by mutation as in TRSB-N.
However, PE2 cleavage also can be inhibited by growth of
TRSB on RPE.40 cells, a toxin-resistant CHO cell line defec-
tive in the furin or furin-like protease responsible for alphavi-
rus PE2 cleavage (21). Both the parent cell line, CHO-KI, and
RPE.40 cells release approximately equal numbers of particles
following infection by Sindbis virus AR339; however, particles
released from RPE.40 cells quantitatively incorporate PE2 and
have much lower specific infectivity than CHO-KI -grown virus
(65). Therefore, the availability of the RPE.40 cell line af-
forded the opportunity to determine whether the suppressor
mutations, which restored viability to PE2-containing
TRSB-N, also would confer viability on PE2-containing TRSB
grown on RPE.40 cells.
CHO-KI and RPE.40 cells were infected with the cloned
TRSB-N revertants and viruses containing the reverting mu-
tations in the TRSB background. Samples of the supernatants
were taken at 20 h postinfection, a time when maximum titer,
as determined by preliminary experiments with representative
mutants, was reached. Virus infectious for BHK-21 cells was
quantitated by plaque assay (Table 3). Although the reverting
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TABLE 2. Virulence of viruses in newborn CD-1 mice
Virus type and clone No. of infected % MortalityAST Virulence phenotypeanoofinflece %Mraiy(days)
Wild-type TRSB 40 100 3.9 ± 0.9 Virulentc
Mutants incorporating PE2 into virions
TRSB-N6R1 21 62 8.8 ± 2.9 Attenuatedd
TRSB-N7R3 26 35 7.9 ± 1.5 Attenuated
TRSB-N8R1 21 28 9.7 ± 1.9 Attenuated
TRSB-N8R2 27 67 8.6 ± 2.6 Attenuated
TRSB-N8R3 35 51 6.6 ± 2.3 Attenuated
TRSB-NE2M198 35 46 7.6 ± 2.8 Attenuated
TRSB-NE2G216 34 44 8.7 ± 2.6 Attenuated
Mutants incorporating E2 into virions
N7R1 22 100 2.8 ± 0.5 Virulent
N7R2 19 100 2.7 ± 0.4 Virulent
TRSB-E3R25 32 100 4.8 ± 1.0 Virulent
TRSB-E2T191 24 100 4.2 ± 0.8 Virulent
TRSB-E2M198 18 100 4.9 ± 0.7 Virulent
TRSB-E2G216 28 100 4.5 ± 0.7 Virulent
TRSB-E2H239 25 100 6.0 ± 1.3 Virulent
" Total number of infected neonates from two to four litters.
bAST, average survival times of infected animals that died ± standard deviations.
c Virulent, causing 100% mortality in infected animals.
d Attenuated, causing < 100% mortality and extended AST in infected animals.
mutations in the TRSB-N background allowed substantial mosquito cells (Fig. 3). TRSB grew to high titers, as assayed on
production of BHK infectious virus in RPE.40 cells compared BHK-21 cells, reaching a plateau of greater than 109 PFU/ml
with production in CHO-Kl, those same mutations in the by 24 h postinfection. Production of infectious virus after
TRSB background did not. Therefore, the reverting mutations infection with each PE2-containing revertant was markedly
appear to be specific for the TRSB-N lesion in PE2 cleavage reduced, by 101 (TRSB-N8R3) to 103-5 (TRSB-N7R3) fewer
rather than being able to compensate for a general failure to PFU than TRSB.
cleave PE2. C6/36 cell growth curves for all viruses containing the
Growth kinetics in invertebrate cell lines. Comparisons reverting mutations in the genetic background of TRSB were
between the S.A.AR86 parental strain and its PE2 cleavage- essentially identical to that for TRSB (Fig. 3). Clearly, these
defective mutant, S12, demonstrated that replication of mutations had no demonstrable effect on growth in the inver-
S.A.AR86 in cultured mosquito cells was greatly influenced by tebrate cells when in the genetic background of a virus that
PE2 cleavage (46). Parental S.A.AR86 consistently grew to cleaves PE2. Therefore, the decreased growth of the PE2-
250-fold or higher titers than S12. To determine whether this containing revertants in C6/36 cells was not attributable to the
applied to the AR339 strain as well, the growth properties of reverting mutations themselves but rather to the failure of
TRSB and of each mutant virus were determined on C6/36 these viruses to cleave PE2.
TABLE 3. Peak titerse of viruses grown on CHO-Kl and RPE.40 cells
Titer (log,( PFU/ml) PFU ratio (RPE.40/CHO-
Virus type and clone
CHO-Kl RPE.40 Kl x 100)
Wild type
TRSB 9.8 6.7 0.1
S.A.AR86 9.2 7.8 4.5
Mutations constructed in pTRSB-N (E2 Asn-1)
TRSB-N6R1 8.8 8.6 66.7
TRSB-N7R3 8.6 7.7 13.7
TRSB-N8R1 9.2 7.8 3.3
TRSB-N8R2 8.9 7.9 9.2
TRSB-N8R3 9.1 8.5 25.0
Mutations constructed in pTRSB (E2 Arg-1)
TRSB-E3R25 9.5 7.0 0.3
TRSB-E2M198 8.9 6.3 0.3
TRSB-E2T191 9.8 7.2 0.3
TRSB-E2H239 9.3 7.2 0.7
TRSB-E2G216 9.7 7.1 0.3
a Virus titers were obtained at 20 h postinfection.
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FIG. 3. Growth kinetics of TRSB and mutant viruses
(A) Growth kinetics of TRSB (+) and five PE2-contaii
of TRSB-N: TRSB-N6RI (A), TRSB-N8RI (0), TRSI
TRSB-N8R3 (A), and TRSB-N8R2 (0). (B) Growth kii
(+) and five viruses containing the reverting mutations
background of TRSB: TRSB-E3R25 (A), TRSB-E2T1'
E2M198 (...+...), TRSB-E2G216 (A), and TRSB-E21
viruses were derived from cDNA clones.
DISCUSSION
Many enveloped RNA viruses appear to regul
tions mediated by their envelope glycoproteins thi
of glycoprotein maturation by cleavage. The
cleavage signal in TRSB is similar in its arrangei
amino acids to the canonical sequence motif (B
Basic) found in the glycoprotein cleavage sites of
flavivirus, retrovirus, orthomyxovirus, paramy
coronavirus families (37). This motif is also i
cleavage site of many prohormones (18). In
several spike functions appear to be linked ti
cleavage immediately downstream of this site in I
glycoprotein PE2. The experiments reported
several issues regarding the role of PE2 cleava~
cycle of Sindbis virus.
PE2 cleavage defects and virus genetic backgi
tions which prevent PE2 cleavage in SFV (51)
equine encephalomyelitis virus (VEE) (7a), anm
strain of Sindbis virus (65; these data) are lethal
Yet, in the genetic background of Sindbis viru
N-linked glycosylation at E2 1 prevented PE2 cle;
to incorporation of PE2 in virions but did not affe
in BHK-21 cells (46, 50). The finding that second-site muta-
tions can suppress the lethality of PE2 cleavage defects in
Sindbis virus AR339 suggests that S.A.AR86 already contains,
within its normal genetic background, sequences which are
compatible with the presence of PE2 in virions.
Genetic reversion of the PE2 cleavage defect. Sequence
analysis of TRSB-N revertants revealed that viability could be
restored to PE2 cleavage-defective mutants in one of two ways.
-_-4 - -- The first was demonstrated by group 1 revertants which
eliminated the site for N-linked glycosylation at E2 1 through
mutation of either the E2 1 or 3 position. Reversion in this case
clearly correlated with restoration of the PE2 cleavage pheno-
type. The second was demonstrated by viable group 2 second-
L site revertants in E2 and E3 which retained the PE2 cleavage
48 60 defect. None of the 22 coding differences between the struc-
tural genes of AR339 and S.A.AR86 (50) map precisely to
residues identified in the group 2 revertants; however, one
difference maps within the region of E2 where reverting
mutations clustered (E2 191 to 239) and the single difference in
E3 (E3 20) is close to the reverting mutation at E3 25.
-:7k7_-_-___---, The E2 191-to-239 region has been identified as an antigeni-
cally important domain in E2, most of which is exposed on the
surface of virions. The E2a neutralization site of Sindbis virus
maps to E2 190 (58, 59). The reverting mutation in N8Rl was
identified at E2 191. The substitution at E2 216 was linked to
reversion of N8R3, and this site maps directly to the E2b
neutralization site at E2 209 to 216 (7, 34, 57). A transitional
epitope that is normally inaccessible on native virions, but
which becomes accessible to monoclonal antibodies following
rearrangement of virions bound at the cell surface, maps to E2
residues 200 to 202 (12, 34). The reverting mutation identified
48 in N7R3 (E2 198) is adjacent to this transitional epitope. The
E2 239 reverting mutation in N8R2 lies outside the known
limits of the major neutralization domain on Sindbis virions.
s in C6/36 cells. However, neutralizing epitopes of VEE and Ross River virus
ning revertants have been identified in the vicinity of E2 239 (19, 62).
N7R3 ( B), Previously, we reported the introduction of an N-linked
netics of TRSB glycosylation site at E2 codon 1 of another AR339-based clone,
s n(0)TRShBc TR4000 (46). Transfection of RNA transcripts from this
H239 (0). All mutant clone (pTR4001-N) gave rise to a stock of PE2-
containing, infectious virions, but only after several days of
incubation. More careful characterization of this mutant clone,
by quantitating the specific infectivity of RNA transcripts,
demonstrated that like TRSB-N, the PE2 cleavage defect was,
in fact, a lethal mutation. We conclude that the experiments
late the func- done in the earlier study with TR4001-N were performed with
rough control virus containing one or more reverting mutations in addition to
four-residue the PE2 cleavage defect.
ment of basic Mechanism of second-site reversion of the cleavage defect.
'asic-X-Basic- Changes in the overall architecture of the glycoprotein spike
viruses in the must form the structural basis for the loss of viability in
xovirus, and TRSB-N and the restoration of viability by the reverting
found at the mutations. This is suggested by the identification of reverting
alphaviruses, mutations not only in E2 but also in E3 and, with the VEE
o proteolytic system, in El (7a). The possible mechanisms by which the
the precursor reverting mutations could restore viability include the follow-
here address ing. The presence of the additional E3 amino acid residues and
ge in the life the carbohydrate side chain at E2 1 may cause a contortion of
the spike into a dysfunctional configuration. A reverting mu-
round. Muta- tation could restore function by recreating a functional spike
, Venezuelan conformation. A second possibility is that in the TRSB-N spike
d the AR339 there is a direct interaction between the E3 domain of PE2
for the virus. (and/or the carbohydrate moiety at E2 1) with a functional
is S.A.AR86, domain elsewhere on the spike. Such an interaction would
avage and led sterically inhibit the activity of the functional domain, while
ct replication mutations which could disrupt such an interaction would
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potentially restore the spike to a functional state. In this
scenario, the reverting mutation at E3 25 may lie within such
an interacting E3 domain, or the Arg-for-Cys replacement
could alter E3 structure by preventing disulfide bond forma-
tion through E3 residue 25. The putative interaction partner
for E3 may be the major neutralization site on E2, the domain
within which most of the reverting mutations lie. This domain
is accessible by monoclonal antibodies on native, wild-type
virions and hence is on the exterior of the spike (34). A third
possibility is that the reverting mutations generate new func-
tional domains on PE2-containing spikes, which perform at
least some of the functions lost because of the presence of the
E3 domain.
Replication step blocked by PE2 cleavage defects. PE2-
containing mutants of SFV (51), and of Sindbis virus TR2001
(10), were impaired in functions of cell binding and of cell
entry. Consistent with these observations, transcripts from
pTRSB-N initiated a single round of infection resulting in the
production of PE2 containing noninfectious particles. This
strongly suggests that the TRSB-N particles fail to complete
one or more of the early phases of normal infection. The two
earliest events in the Sindbis virus infectious cycle occur on the
topographic exterior of the cell: attachment to the receptor(s)
and subsequent structural rearrangement of the glycoprotein
spikes, as detected by monoclonal antibody binding to epitopes
inaccessible on native virions (12, 34). This initial conforma-
tional change is followed by entry either by fusion of the
envelope with the plasma membrane (1, 4) or by endocytosis
(16, 32). PE2-containing virions may be excessively stable and
thus unable to undergo a requisite rearrangement at the cell
surface (12) or in endosomes after endocytosis (51). Experi-
ments are in progress to determine the early event(s) affected
in TRSB-N infection by utilizing comparisons between TRSB,
TRSB-N, and PE2-containing second-site revertants of
TRSB-N.
Effect of E2 residue 1 on efficiency of cleavage. The residue
at the +1 position relative to the PE2 cleavage signal varies
among alphaviruses (2, 5, 27, 50), and Sindbis virus AR339 can
tolerate several residues at the +1 position relative to the
cleavage site, including Arg (6), Ser (48), Asp (revertant
N7R2), and Asn (revertant N7R1). Examination of SDS-
PAGE profiles of virion glycoproteins containing these toler-
ated residues suggests that the residue at E2 1 can affect the
efficiency of PE2 cleavage (Fig. 2 and data not shown). A
Phe-to-Leu mutation at the residue occupying the analogous
position in the F protein of Newcastle disease virus inhibited
cleavage of this viral glycoprotein and was correlated with the
loss of fusion activity and decreased virulence in animals (36).
Inhibition of PE2-containing revertants in mosquito cells.
Infection with PE2-containing revertant viruses of Sindbis
virus S.A.AR86 (46) and AR339 resulted in poor production of
infectious virus in cultured mosquito cells. This likely reflects a
difference(s) in the virus-host cell interactions affected by
incorporation of PE2 during replication in BHK-21 cells as
opposed to C6/36 cells. In the case of the S.A.AR86 S12
mutant, the block appeared to be at a late stage in infection
(46), and the basis for the inhibition of AR339-derived strains
is under active investigation. Alphaviruses must replicate in
both vertebrate and invertebrate hosts to be maintained in
nature. While mutations that prevent PE2 processing may be
tolerated in the vertebrate host, these would be selected
against in the mosquito vector.
In vivo attenuation of PE2-containing mutants. Incorpora-
tion of PE2 attenuated the virulence of S.A.AR86, and of each
group 2 revertant of AR339, in newborn CD-1 mice. Thus,
normal or nearly normal growth of these viruses in BHK-21
cells did not correlate with wild-type virulence in the mouse
system. This may reflect the fact that each revertant was
selected by growth in BHK-21 cells and that the effect of PE2
incorporation on replication in BHK-21 cells and in specific
differentiated cell types in vivo may be fundamentally different.
For instance, different putative Sindbis virus receptors have
been identified on BHK-21 cells (64) and on mouse neuroblas-
toma cells (60). Therefore, it is possible that the reverting
mutations have restored the ability of PE2-containing viruses
to initiate infection of BHK-21 cells but not of important cell
types in mice. Experiments are in progress to determine which
cell and tissue tropism differences in vivo distinguish PE2-
containing revertants from TRSB.
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